Skip to main content
Equibles

SJS Investment Consulting Inc.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1894302 SYLVANIA, OH
Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$42,977
-$1,946 QoQ
Shares Held
255
-25.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#646
of 774 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SJS Investment Consulting Inc. holds $550,595 across 35 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HROW
Harrow, Inc.
 6,073 $257,920
2 ZTS
Zoetis Inc.
 770 $55,331
3 NBIX
Neurocrine Biosciences Inc
This page 		255 $42,977
4 TAK
Takeda Pharmaceutical Co Ltd
 2,285 $36,627
5 UTHR
UNITED THERAPEUTICS Corp
 54 $29,258
6 ELAN
Elanco Animal Health Inc
 1,180 $29,039
7 VTRS
Viatris Inc
 895 $14,212
8 HIMS
Hims & Hers Health, Inc.
 348 $12,064

All Filings in NBIX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $42,977 255
2026-03-31 $44,923 341
2025-12-31 $28,932 204
2025-09-30 $982 7
2025-06-30 $754 6
2025-03-31 $774 7
2024-12-31 $1,365 10
2024-09-30 $691 6
2024-06-30 $1,239 9
2024-03-31 $551 4
2023-12-31 $527 4
2023-09-30 $337 3
2023-06-30 $282 3
2022-12-31 $358 3
2022-09-30 $424 4
2022-03-31 $187 2